DoRevision

Trial by Science

From foxglove to pharmacy: how a new drug is discovered, tested and trialled. Preclinical, clinical, placebo and double-blind.

⏱️ 9 min 🎯 13 activities
Best used for
Starter Independent study

Work it through together, step by step

A free interactive activity that works the method through with a class, step by step.

Start revising free

What you'll cover

Trial by Science

Before a new medicine reaches a pharmacy it faces years of testing, designed to answer two questions: is it **safe**, and does it **work**? Many drugs started out extracted from **plants and microorganisms**: • **Digitalis**: a heart drug from **foxgloves**. • **Aspirin**: a painkiller from **willow** bark. • **Penicillin**: the first antibiotic, discovered by **Alexander Fleming** from the **Penicillium mould**. This module follows a drug from its source through preclinical testing and human trials to approval.

Name the source

The antibiotic **penicillin** was originally discovered from what?

  • A mould, discovered by Alexander Fleming
  • The foxglove plant
  • Willow bark
  • An animal

Three questions

Every potential new drug is tested for three things, and the exam wants the term, not the paraphrase:

Match the terms

  • Toxicity
  • Efficacy
  • Dose
  • Is the drug harmful?
  • Does the drug actually work?
  • How much should be given?

Two stages of testing

Testing runs in two big stages, and a question naming one rarely wants the other. Safety always comes before dose: you never give a large dose until you know it is not toxic.

Order the testing

Put the stages of testing a new drug into the correct order, from first to last.

  • Test on cells and tissues in the lab
  • Test on live animals
  • Test on healthy volunteers at a very low dose
  • Test on patients to find the optimum dose

Removing bias

To trust the results, trials are designed to remove **bias**: • A **placebo** is a dummy treatment with no active drug. Some patients get it so the drug's effect can be compared fairly. • In a **double-blind** trial, **neither the patients nor the doctors** know who got the real drug. so expectations can't sway the result. • Finally, results are **peer reviewed**: checked by other scientists before publication. To catch false claims.

Who knows?

In a **double-blind** trial, who knows which patients are getting the real drug rather than the placebo?

  • Neither the patients nor the doctors
  • Only the doctors
  • Only the patients
  • Everyone is told

Complete the process

New drugs are first tested in the lab on cells, tissues and _____, then in clinical trials on human _____. To remove bias, trials are often _____.

animals volunteers double-blind harmful

True of clinical trials?

Pick the TWO correct statements about clinical trials.

  • Healthy volunteers are tested first, at low doses, to check safety
  • In a double-blind trial neither doctor nor patient knows who got the real drug
  • New drugs skip lab testing and go straight to patients
  • Patients are always told immediately if they got the placebo

Design the trial

A new drug has passed preclinical testing. You are designing the human trial. Make three decisions.

  • Who receives the drug first, and at what dose?
  • Half your patients improve. How do you show the drug caused it?
  • Your doctors know which patients got the real drug, and you are worried it is colouring their assessments. What do you change?

Explain the order

Explain why a new drug is given to healthy volunteers at a very low dose before it is ever given to patients. Take the reasoning through to what would go wrong otherwise.

  • Say which of the three questions the first stage is trying to answer
  • Say why a low dose is used rather than the dose you hope will work
  • Say what the risk would be if patients were given a full dose first

In the exam

Trial complete. Grade-9 habits for drug development: • Drugs are tested for **toxicity, efficacy and dose**: **safety first**, always. • **Preclinical** = cells, tissues, animals; **clinical** = healthy volunteers then patients. • **Placebo** and **double-blind** remove bias; **peer review** checks the results before they're published.